Prescribing a medicine is the most common intervention after an NHS consultation. When used appropriately, medicines are important to manage symptoms, improve outcomes and prevent adverse outcomes for many patients living with long term conditions.
Overprescribing is the use of a medicine where there is a better non-medicine alternative, or the use is not best suited for the individual patient’s circumstances and wishes. When medicines are overprescribed, they can lead to poor patient outcomes and harm, health inequalities, medicines wastage, financial inefficiencies, and a negative impact on the environment.
Overprescribing is a complex problem caused and driven by multiple, interdependent factors.
In September 2021, a 3-year national program was launched to coordinate the implementation of the 20 cross-system recommendations of the National Overprescribing Review Report (NOR report). This report acknowledged that Integrated Care Systems (ICS) can leverage the opportunities of integrated and collaborative working to deliver system wide solutions to tackle overprescribing, improving population health, reducing inequalities and improving productivity.
The South East London Overprescribing Programme draws from the experience of stakeholders across the system, and seeks to:
Five priority areas were identified to enable this programme: